COG Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £25,933.50
Insider Selling (Last 12 Months): GBX 0

Cambridge Cognition Insider Trading History Chart

This chart shows the insider buying and selling history at Cambridge Cognition by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cambridge Cognition Share Price & Price History

Current Price: GBX 110.50
Price Change: Price Increase of +3 (2.79%)
As of 02/2/2023 01:00 AM ET

This chart shows the closing price history over time for COG up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Cambridge Cognition Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/21/2022Matthew StorkInsiderBuy22,950GBX 113£25,933.50
See Full Table

SEC Filings (Institutional Ownership Changes) for Cambridge Cognition (LON:COG)

Cambridge Cognition logo
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB Recruit, an online trial recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases I-IV; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication. It also provides CANTAB Connect Research, a research software that offers sensitive digital measures of cognitive function for various areas of brain research; CANTAB Mobile, a touchscreen memory test used in clinical research of Alzheimer's disease; CANTAB BrainHealth, an online digital health assessment tool to measure and monitor mental wellbeing and cognitive performance in the workplace; CANTAB Insight, a medical device that helps to determine an individual's cognitive health; and NeuroVocalix for an automated administration and scoring of well-validated verbal cognitive assessments?on a secure platform. In addition, the company offers a range of expert consultancy and operational management services to optimize clinical trials and cognitive research, which include neuroscience and technical consultancy, study design, data analysis, study and data management, and reports and interpretation. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.
Read More on Cambridge Cognition

Today's Range

Now: GBX 110.50
Low: 105.60
High: 111.24

50 Day Range

MA: GBX 117.61
Low: 107.50
High: 124

52 Week Range

Now: GBX 110.50
Low: 102.22
High: 189.88

Volume

104,741 shs

Average Volume

75,894 shs

Market Capitalization

£34.44 million

P/E Ratio

11,050.00

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Cambridge Cognition?

Cambridge Cognition's top insider shareholders include:
  1. Matthew Stork (Insider)
Learn More about top insider investors at Cambridge Cognition.